• What is CMT?
    • About CMT
    • Type1
      • What is CMT1A?
      • What is CMT1B?
      • What is CMT1E?
      • What is HNPP?
    • Type2
      • What is CMT2A?
    • Type4
      • What is SORD?
    • TypeX
      • Understanding CMT1X/CMTX1 and GJB1
    • —-
    • Frequently Asked Questions
    • Watch Our Video Series
    • Learn About Treatments in Development
  • Research
    • Research Approach
    • Research Projects We Fund
    • Gene Therapy
    • —-
    • Apply for Funding
    • George and Cleary Simpson Award for Emerging Researchers
    • Community Leaders in 4C
  • NODE
    • NODE Platform
    • Learn More about NODE
    • NODE Request for Proposals
  • News & Stories
    • News
    • 2026 Annual Report
    • CMT Stories
    • Webinars
  • Take Action
  • About Us
    • Who We Are
    • Board of Directors
    • Research Advisory Council
    • Scientific Advisory Board
    • Research Foundation Staff
    • Events
    • Financials
    • Contact Us
    • Velocity
    • Global CMT Research Convention
  • Donate

CMT Research Updates

$90M Setara Launch Showcases Growing Momentum for CMT Research

$90M Setara Launch Showcases Growing Momentum for CMT Research

Nov 6, 2026 | CMT Drug Development, CMT Research News, CMT Research Updates, CMTRF Blog & Articles

Setara Biosciences launched on October 30, 2026 with a $90 million Series A financing to develop treatments for rare genetic diseases, with Charcot-Marie-Tooth disease type 2C (CMT2C) as its lead focus.   The company was spun out of Actio Biosciences. Earlier this...

read more
CMTRF Launches the 2026 Global CMT Research Convention Virtual Experience

CMTRF Launches the 2026 Global CMT Research Convention Virtual Experience

Oct 29, 2026 | CMT Drug Development, CMT Research News, CMT Research Updates, CMTRF Foundation News

The CMT Research Foundation has launched a new way to watch the 2026 Global CMT Research Convention. The convention video platform puts the full program in one place, so you can revisit a session you attended or explore the convention for the first time.  Browse by...

read more
Virtual Workshop: Get the Most out of NODE

Virtual Workshop: Get the Most out of NODE

Oct 15, 2026 | CMT Research News, CMT Research Updates, CMTRF Foundation News, CMTRF Funded Research

https://youtu.be/f6o9ERWhC4Y This workshop is built for scientists who are interested in using the Neuropathy Open Data Exchange (NODE), a resource from the CMT Research Foundation for peripheral nerve researchers to share data. Learn more about: Everything the...

read more
CMT Orgs Come together to Advocate for New Clinical Trial Framework

CMT Orgs Come together to Advocate for New Clinical Trial Framework

Aug 5, 2026 | CMT Research Updates

Organizations focused on Charcot-Marie-Tooth (CMT) disease have aligned with clinicians, and pharmaceutical companies to share a set of recommendations for how CMT clinical trials should be designed, with the recommendations published in Journal of the Peripheral...

read more
Introducing the CMTRF Journal Club: A New Interactive Series for CMT Researchers

Introducing the CMTRF Journal Club: A New Interactive Series for CMT Researchers

Jul 14, 2026 | CMT Research Updates

The CMT Research Foundation is launching a new Journal Club webinar series designed specifically for researchers working in the CMT space. Each session will spotlight a recent, high-impact publication, with a short presentation from the research team followed by open...

read more
Scientific Takeaways from the Peripheral Nerve Society’s Conference

Scientific Takeaways from the Peripheral Nerve Society’s Conference

Jun 23, 2026 | CMT Research Updates

The Peripheral Nerve Society hosted its annual conference in the Netherlands this June, and our research team went to learn about the latest advances, network with field leaders and accelerate progress for CMT treatments and cures.  Here are our scientific team's...

read more
WEBINAR: Gene Therapies Demystified, Policy, Access, and the Road Ahead

WEBINAR: Gene Therapies Demystified, Policy, Access, and the Road Ahead

Jun 18, 2026 | CMT Research Updates

https://youtu.be/AzOoaWPYpyc?si=44PoEHPxatjopWc- The first session of the CMT Research Foundation’s Gene Therapies Demystified series gave attendees the building blocks: what gene therapy is, why CMT is a compelling target, and what the science suggests about its...

read more
Project Report: A new way to deliver drugs to nerves in CMT

Project Report: A new way to deliver drugs to nerves in CMT

Jun 18, 2026 | CMT Research Updates, CMTRF Funded Research

One of the biggest obstacles in CMT research is not a shortage of potential therapies, but a delivery problem: nerves are extremely difficult to reach through the bloodstream. Dr. Kelly Langert's team at Loyola University Chicago took a creative approach, asking...

read more
CMT1A Patients Dosed in Korean Phase 2a Drug Trial

CMT1A Patients Dosed in Korean Phase 2a Drug Trial

May 20, 2026 | CMT Research Updates

ENCell, a South Korean company focused on cell and gene therapies, announced in May 2026 (as reported by Korean outlet The Bio News) that the first patient has been dosed in a Phase 2a clinical trial of EN001, a treatment candidate for Charcot-Marie-Tooth disease Type...

read more
WEBINAR: Gene Therapies Demystified, Understanding the Fundamentals for CMT

WEBINAR: Gene Therapies Demystified, Understanding the Fundamentals for CMT

Apr 16, 2026 | CMT Research Updates, CMTRF Foundation News

https://www.youtube.com/watch?v=hrNkyIHed8U One of the most rapidly expanding frontiers in Charcot-Marie-Tooth research is also one of the most challenging to keep pace with. Now, the CMT Research Foundation is making it accessible to everyone. The CMTRF launched Gene...

read more
« Older Entries

Search Articles

Categories

  • About CMT Disease
  • CMT Drug Development
  • CMT Research News
  • CMT Research Updates
  • CMTRF Blog & Articles
  • CMTRF Foundation News
  • CMTRF Funded Research
  • Life with CMT Stories

Help us find a cure.

Donate Now
Donate Now

Help us find a cure.

NEWSLETTER SIGNUP

Stay up to date on new CMT research, treatments and clinical trials



Address

4062 Peachtree Road
Suite A209
Atlanta, GA 30319



Phone Number

404.806.7180



EMAIL

[email protected]

  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

© 2026 CMT Research Foundation | Privacy Policy

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}